STAT | A decade of reporting from the frontiers of health and medicine

Skip to Main Content

Experience STAT's journalism live at an upcoming STAT Summit

Experience STAT's journalism live at an upcoming STAT Summit

April 1, 2026

STAT Plus: Insilico Medicine CEO on how best to use AI in drug development
April 1, 2026

Medicare is restricting care for 1 million Americans based on a faulty assumption. Congress must intervene
April 1, 2026

STAT Plus: The biotech scorecard for the second quarter: 23 stock-moving events to watch
March 31, 2026

STAT Plus: HHS changes the U.S. health IT office’s name, and its purview
March 31, 2026

STAT Plus: Baby KJ scientists hit speed bump in quest to scale custom gene editor
March 31, 2026

Supreme Court rules against Colorado ban on ‘conversion therapy’ for LGBTQ kids

Test your knowledge with our now weekday mini crossword

Play the STAT Mini

The 2026 STAT Madness bracket is live!

Eli Lilly’s obesity pill approved by FDA, setting up fierce competition with Novo Nordisk

Consumers have already shown strong early interest in GLP-1 oral medications, which can be easily distributed and don't require cold storage.

Health April 1, 2026

Why an ovary syndrome may get a new name: Men seem to have PCOS, too

Politics April 1, 2026

STAT Plus: NIH director’s invocation of Vannevar Bush’s legacy to promote Trump science policies sparks pushback

First Opinion April 1, 2026

Medical marijuana should not be recommended for PTSD, anxiety, or depression

Health April 1, 2026

STAT Plus: Can a psychedelic ‘coach’ make ketamine therapy even more effective?

Sponsored

Advertisement

Sign up for Newsletters

STAT+

Your go-to source for the world of life sciences, medicine, and biopharma. Subscribe now.

Cancel anytime.

STAT Plus: Baby KJ scientists hit speed bump in quest to scale custom gene editor

STAT Plus: Epic says it has uncovered rot in patient record sharing. Will HHS act?

STAT Plus: Early signs of Alzheimer’s often go undetected. These researchers want to change that

STAT Plus: Doctors Without Borders calls Gilead ‘unconscionable’ for refusing to sell HIV prevention drug to the organization

STAT Plus: Why this Stanford psychiatrist thinks diet can influence serious mental health disorders

All STAT+ Stories

All Events

More From STAT

More From STAT

More From STAT

STAT offers a variety of in-person and virtual events throughout the year.

All Events

STAT@AACR: Outsmarting Cancer

San Diego, CA

Live from San Diego during AACR 2026, STAT and top experts unpack the most important breakthroughs emerging in cancer research.

AACR 2026: The STAT Recap

Virtual

2026 Breakthrough Summit West

San Francisco, CA

STAT@ASCO: Science vs. Cancer

Chicago, IL

All Events

All Trackers

More From STAT

More From STAT

More From STAT

We create tools to help you understand and track complex areas of development.

All Trackers

Obesity Drug Tracker

Here are the dozens of weight loss drugs in development to catch a booming market.

CRISPR Tracker

Follow the latest developments in genome editing.

Generative AI Tracker

A guide to the health systems and companies driving adoption.

Breakthrough Device Tracker

An authoritative database of FDA’s fast-tracked medical devices.

All Reports

More From STAT

More From STAT

More From STAT

STAT Reports blend data insights with qualitative observations on pivotal life sciences topics.

All Reports

Chaotic and politicized: Inside the FDA under Trump

$49

Explore how turmoil and political pressure have destabilized the agency with mass layoffs, rapid staff departures, and a revolving door of leadership.

All Podcasts

More From STAT

More From STAT

More From STAT

From policy to practice: STAT's podcasts decode health care complexities.

All Podcasts

The Readout LOUD

Our weekly biotech podcast digs deep into industry goings-on.

First Opinion Podcast

A weekly interview show featuring the most interesting people and ideas in medicine.

Color Code

Enjoy the archives of Color Code, our podcast on racial inequities in American health care.

More From STAT

View upcoming events Play the STAT Mini Crossword Explore trackers Download our latest Report Listen to STAT podcasts

More Stories

AI Prognosis April 1, 2026

STAT Plus: Insilico Medicine CEO on how best to use AI in drug development

First Opinion April 1, 2026

Medicare is restricting care for 1 million Americans based on a faulty assumption. Congress must intervene

Biotech April 1, 2026

STAT Plus: The biotech scorecard for the second quarter: 23 stock-moving events to watch

Health tech March 31, 2026

STAT Plus: HHS changes the U.S. health IT office’s name, and its purview

Biotech March 31, 2026

STAT Plus: Baby KJ scientists hit speed bump in quest to scale custom gene editor

Politics March 31, 2026

Supreme Court rules against Colorado ban on ‘conversion therapy’ for LGBTQ kids

Health Tech Newsletter March 31, 2026

STAT Plus: OpenEvidence inks deal with major health system

Health tech March 31, 2026

STAT Plus: Whoop, maker of health and fitness tracking wristbands, valued at $10 billion after latest fundraising

Biotech March 31, 2026

STAT Plus: Biogen to acquire immunology biotech Apellis for $5.6 billion

Pharma March 31, 2026

STAT Plus: Eli Lilly to buy Centessa Pharmaceuticals, maker of a narcolepsy drug, in $6.3B deal

First Opinion March 31, 2026

How the next CDC director can win back America’s trust

Exclusive March 31, 2026

STAT Plus: HSA companies struck it big in Trump’s tax bill. They’re lobbying for more

The Readout April 1, 2026

STAT Plus: Novo’s subscription model raises questions about pharma-telehealth tie-ups

Pharmalot April 1, 2026

STAT Plus: Pharmalittle: We’re reading about FDA view on peptide compounding, Iran war hurting trial recruitment, and more

D.C. Diagnosis March 31, 2026

STAT Plus: The HSA industry makes its MAHA pitch

Pharmalot March 31, 2026

STAT Plus: Pharmalittle: We’re reading about pharma delaying launches in Europe, Lilly and Biogen deals, and more

The Readout March 31, 2026

STAT Plus: Psychedelic biotechs face scrutiny over YouTube promos

Biotech March 31, 2026

STAT Plus: Biotech VCs move upstream in China’s scientific pipelines as competition grows fiercer

First Opinion April 1, 2026

Medicare is restricting care for 1 million Americans based on a faulty assumption. Congress must intervene

First Opinion April 1, 2026

Medical marijuana should not be recommended for PTSD, anxiety, or depression

First Opinion March 31, 2026

America needs more clinics of last resort for patients who can’t get answers

First Opinion March 31, 2026

How the next CDC director can win back America’s trust

Opinions+ March 30, 2026

STAT Plus: Washington is on the verge of true PBM reform

First Opinion March 30, 2026

Remembering public health pioneer Barry Bloom: a scientist, a mentor, a mensch

Newsletters

Our Picks

Our Picks

STAT’s selection of must-read stories and investigations

Her son needed a fecal transplant for a fearsome C. diff infection. Getting one required a tortuous journey

By Eric Boodman

NIH restrictions on foreign research partnerships significantly impacted 1 in 4 U.S. scientists

By Megan Molteni, Anil Oza, and Jonathan Wosen

STAT Plus: How a Texas couple is getting rich off out-of-network medical bills

STAT Plus: Can you spot a deepfake X-ray? Neither can your radiologist

By Katie Palmer

How STAT would cover ‘The Fugitive’ if its pharma scandal were real

By STAT Staff

National survey of NIH-funded researchers shows precarious state of U.S. science — ‘This is like the Titanic’

By Jonathan Wosen

The indirect — and sometimes surprising — benefits of vaccines

By Helen Branswell

STAT Plus: New technologies promise to transform organ transplantation. But when?

By Elizabeth Cooney

STAT Plus: Pharma giant Takeda to lay off nearly 250 workers in latest job cutting

Biotech March 30, 2026

STAT Plus: Pharma giant Takeda to lay off nearly 250 workers in latest job cutting

Biotech March 29, 2026

STAT Plus: AI drug developer Insilico Medicine and Lilly ink commercialization deal worth up to $2.75 billion

Biotech March 26, 2026

STAT Plus: FDA approves Rocket gene therapy for rare immune disorder

STAT Plus: Pharmalittle: We’re reading about Trump pushing drug pricing policy, Chinese biotech licensing, and more

Pharmalot March 30, 2026

STAT Plus: Pharmalittle: We’re reading about Trump pushing drug pricing policy, Chinese biotech licensing, and more

Pharmalot March 27, 2026

STAT Plus: Up and down the ladder: The latest comings and goings

Pharmalot March 27, 2026

STAT Plus: Pharmalittle: We’re reading about Novo Nordisk boosting consumer focus, FDA approving a gene therapy, and more

Lead still raises risk of heart disease, years after exposure, study warns

Health March 30, 2026

Lead still raises risk of heart disease, years after exposure, study warns

Health March 30, 2026

7 big challenges for the next CDC director

Health March 27, 2026

Decades after Vietnam War, research links Agent Orange exposure to MDS blood cancer

STAT Plus: Amid focus on food, FDA leader briefs lawmakers on priorities

Politics March 27, 2026

STAT Plus: Amid focus on food, FDA leader briefs lawmakers on priorities

Politics March 27, 2026

STAT Plus: ‘We’re on the inside now’: Meet the man building a political empire behind RFK Jr.

Politics March 27, 2026

STAT Plus: Trump administration says home care fraud is ‘rampant.’ What do the data show?

Video

Health influencers talk social media and mental health

STAT Plus: Inside the delicate, high-stakes search for a new CDC director

How STAT would cover ‘The Fugitive’ if its pharma scandal were real

How the ‘holy grail’ weight loss pill became a reality, and what comes next

STAT Plus: Jimini Health raises funding for AI chatbot targeting complex mental health care

Health tech March 31, 2026

STAT Plus: Jimini Health raises funding for AI chatbot targeting complex mental health care

Health tech March 25, 2026

STAT Plus: Qualified Health raises $125 million, as it helps more health systems build and manage AI tools

Health tech March 23, 2026

STAT Plus: Doctronic raises $40 million as race to apply AI in clinical care heats up

What growing up in an end-times church taught a science communicator about dispelling misinformation

In the Lab March 24, 2026

What growing up in an end-times church taught a science communicator about dispelling misinformation

In the Lab March 23, 2026

NIH grant terminations affected women scientists more than men, study finds

In the Lab March 20, 2026

STAT Plus: A family’s giving to the Broad Institute’s research tops $1 billion

STAT Plus: Leapfrog Group’s legal defeat underscores challenges of rating hospital quality

Hospitals March 13, 2026

STAT Plus: Leapfrog Group’s legal defeat underscores challenges of rating hospital quality

Hospitals March 10, 2026

STAT Plus: After fight over cancer clinicians, Dana-Farber and Brigham are playing nice again

Hospitals February 16, 2026

STAT Plus: Breakup between Brigham and Dana-Farber is getting messier fast

STAT Plus: Medicare Advantage growth dwindles for a second straight year

Insurance February 16, 2026

STAT Plus: Medicare Advantage growth dwindles for a second straight year

Insurance February 9, 2026

STAT Plus: Federal government turns to fresher data to rein in Medicare Advantage upcoding

Insurance January 12, 2026

STAT Plus: UnitedHealth has turned Medicare Advantage coding into ‘profit-centered strategy,’ Senate report finds

Podcasts

Eli Lilly’s deal man, Allogene’s off-the-shelf CAR-T, and Merck’s Terns buy

A conversation with the ‘godfather’ of biotech

Epstein’s pal attempts a biotech comeback, and Prasad exits the FDA

STAT Plus: Breaching the IBD efficacy ceiling, and sham surgeries